Source: Human Gene Therapy. Conference titles: Conference of Changing the Face of Modern Medicine: Stem Cell and Gene Therapy. Unidade: ICB
Subjects: IMUNOLOGIA, CÉLULAS-TRONCO, GENES, GRANULOMA, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, MUTAÇÃO GENÉTICA, IMUNOGENÉTICA, GRANULÓCITOS, GENÉTICA
ABNT
SCHEJTMAN, A. et al. Towards clinical application of a lentiviral gene therapy protocol for p47phox deficient chronic granulomatous disease. Human Gene Therapy. New Rochelle: Mary Ann Liebert, Inc. Publishers. Disponível em: https://doi.org/10.1089/hum.2018.29077.abstracts. Acesso em: 23 ago. 2024. , 2018APA
Schejtman, A., Aragão Filho, W. C., Clare, S., Weisser, M., Zinicola, M., Burns, S., et al. (2018). Towards clinical application of a lentiviral gene therapy protocol for p47phox deficient chronic granulomatous disease. Human Gene Therapy. New Rochelle: Mary Ann Liebert, Inc. Publishers. doi:10.1089/hum.2018.29077.abstractsNLM
Schejtman A, Aragão Filho WC, Clare S, Weisser M, Zinicola M, Burns S, Thomas D, Thrasher AJ, Santilli C. Towards clinical application of a lentiviral gene therapy protocol for p47phox deficient chronic granulomatous disease [Internet]. Human Gene Therapy. 2018 ; 29( 12): A27-A27.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1089/hum.2018.29077.abstractsVancouver
Schejtman A, Aragão Filho WC, Clare S, Weisser M, Zinicola M, Burns S, Thomas D, Thrasher AJ, Santilli C. Towards clinical application of a lentiviral gene therapy protocol for p47phox deficient chronic granulomatous disease [Internet]. Human Gene Therapy. 2018 ; 29( 12): A27-A27.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1089/hum.2018.29077.abstracts